Allianz Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-326,305
| Closed | -$33.1M | – | 2046 |
|
|
2025
Q4 | $33.1M | Buy |
326,305
+232,529
| +248% | +$18.7M | 0.03% | 433 |
|
|
2025
Q3 | $5.13M | Buy |
+93,776
| New | +$4.69M | 0.01% | 1110 |
|
|
2025
Q2 | – | Sell |
-14,397
| Closed | -$623K | – | 2094 |
|
|
2025
Q1 | $623K | Sell |
14,397
-9,103
| -39% | -$461K | ﹤0.01% | 1810 |
|
|
2024
Q4 | $1.32M | Buy |
23,500
+1,997
| +9% | +$124K | ﹤0.01% | 1567 |
|
|
2024
Q3 | $1.46M | Buy |
21,503
+9,656
| +82% | +$545K | ﹤0.01% | 1515 |
|
|
2024
Q2 | $501K | Sell |
11,847
-3,999
| -25% | -$220K | ﹤0.01% | 1836 |
|
|
2024
Q1 | $1.09M | Sell |
15,846
-4,419
| -22% | -$280K | ﹤0.01% | 1383 |
|
|
2023
Q4 | $1.5M | Buy |
20,265
+4,986
| +33% | +$327K | ﹤0.01% | 1439 |
|
|
2023
Q3 | $1.04M | Sell |
15,279
-1,089
| -7% | -$92.4K | ﹤0.01% | 1690 |
|
|
2023
Q2 | $1.54M | Sell |
16,368
-158,086
| -91% | -$12.3M | ﹤0.01% | 1402 |
|
|
2023
Q1 | $11.8M | Buy |
174,454
+1,242
| +0.7% | +$79.8K | 0.02% | 629 |
|
|
2022
Q4 | $8.58M | Sell |
173,212
-22,758
| -12% | -$930K | 0.02% | 727 |
|
|
2022
Q3 | $6.37M | Buy |
195,970
+6,495
| +3% | +$268K | 0.01% | 799 |
|
|
2022
Q2 | $7.46M | Buy |
189,475
+43,423
| +30% | +$2.32M | 0.01% | 977 |
|
|
2022
Q1 | $10.2M | Sell |
146,052
-1,529
| -1% | -$112K | 0.01% | 986 |
|
|
2021
Q4 | $11.5M | Buy |
147,581
+217
| +0.1% | +$19.2K | 0.01% | 943 |
|
|
2021
Q3 | $14.1M | Buy |
147,364
+49,800
| +51% | +$5.26M | 0.01% | 867 |
|
|
2021
Q2 | $12.1M | Sell |
97,564
-1,641
| -2% | -$196K | 0.01% | 785 |
|
|
2021
Q1 | $13.1M | Buy |
99,205
+72,116
| +266% | +$9.87M | 0.01% | 748 |
|
|
2020
Q4 | $3.59M | Buy |
27,089
+5,575
| +26% | +$674K | ﹤0.01% | 1149 |
|
|
2020
Q3 | $2.19M | Sell |
21,514
-146,673
| -87% | -$12.7M | ﹤0.01% | 1234 |
|
|
2020
Q2 | $14.6M | Sell |
168,187
-101,149
| -38% | -$8.08M | 0.02% | 749 |
|
|
2020
Q1 | $15.6M | Sell |
269,336
-234,783
| -47% | -$19.1M | 0.02% | 656 |
|
|
2019
Q4 | $46.6M | Buy |
504,119
+448,895
| +813% | +$39.5M | 0.04% | 457 |
|
|
2019
Q3 | $4.99M | Sell |
55,224
-55,605
| -50% | -$6.34M | ﹤0.01% | 1442 |
|
|
2019
Q2 | $13.1M | Sell |
110,829
-73,180
| -40% | -$7.37M | 0.01% | 1036 |
|
|
2019
Q1 | $15.9M | Sell |
184,009
-36,188
| -16% | -$3.08M | 0.02% | 867 |
|
|
2018
Q4 | $13.9M | Buy |
220,197
+138,597
| +170% | +$9.51M | 0.02% | 938 |
|
|
2018
Q3 | $6.44M | Buy |
+81,600
| New | +$5.32M | 0.01% | 1449 |
|
|
2018
Q2 | – | Sell |
-22,719
| Closed | -$917K | – | 2641 |
|
|
2018
Q1 | $917K | Buy |
22,719
+15,786
| +228% | +$770K | ﹤0.01% | 2237 |
|
|
2017
Q4 | $364K | Sell |
6,933
-135,266
| -95% | -$7.22M | ﹤0.01% | 2493 |
|
|
2017
Q3 | $6.7M | Sell |
142,199
-22,356
| -14% | -$900K | 0.01% | 1483 |
|
|
2017
Q2 | $5.82M | Buy |
164,555
+101,215
| +160% | +$3.12M | 0.01% | 1533 |
|
|
2017
Q1 | $1.5M | Buy |
+63,340
| New | +$1.26M | ﹤0.01% | 2100 |
|
|
2014
Q3 | – | Sell |
-135,333
| Closed | -$2.31M | – | 2335 |
|
|
2014
Q2 | $2.31M | Sell |
135,333
-758
| -0.6% | -$10.4K | ﹤0.01% | 1154 |
|
|
2014
Q1 | $1.93M | Sell |
136,091
-8,204
| -6% | -$111K | ﹤0.01% | 1217 |
|
|
2013
Q4 | $1.69M | Sell |
144,295
-8,349
| -5% | -$95.8K | ﹤0.01% | 1256 |
|
|
2013
Q3 | $1.8M | Buy |
+152,644
| New | +$1.96M | ﹤0.01% | 1218 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Allianz Asset Management's EXAS Position: Q1 2026 in Review
Allianz Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 326,305 shares — an estimated $33.1M sold.
Allianz Asset Management first reported a position in EXAS in Q3 2013 and held it in 38 quarters. The position peaked at $46.6M in Q4 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Allianz Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Allianz Asset Management sold 326,305 Exact Sciences shares in Q1 2026, an estimated $33.1M.
- Allianz Asset Management first reported a position in Exact Sciences in Q3 2013 and held it in 38 quarters.
- Allianz Asset Management's Exact Sciences position peaked at $46.6M in Q4 2019.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.